While compelling, a lack of clinical evidence has left researchers skeptical of Akkermansias efficacy, warning that more studies are needed
Large-scale clinical trials are needed to fully understand the effects of GLP-1RAs on ICP, headache outcomes, visual prognosis and quality of life in IIH patients
A., Li, D., Messerschmidt, M., Boutet, S., Williams, G
Common barriers include: You've already lost weight and no longer meet the starting BMI requirement
Both labels note that the delay in gastric emptying is dose-dependent, largest after the first dose, and diminishes with subsequent doses
Look for clean formulas, ideally third-party tested for quality